Effect of antiangiogenic treatment on peritoneal endometriosis-associated nerve fibers

Edurne Novella-Maestre, Novella-Maestre E, Sonia Herraiz, José María Vila-Vives, Vila-Vives JM, Carmen Cardá, Carda C, Carmen Carda, Amparo Ruiz-Sauri, Ruiz-Sauri A, Amparo Ruiz‐Saurí, António Pellicer, Antonio Pellicer
Fertility and sterility · 2012 · vol. 98(5) , pp. 1209–1217 · doi:10.1016/j.fertnstert.2012.07.1103 · PMID:22921078 · W2067360409
Lab / animal OA: closed CC0 ⤵ 39 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This study investigated how antiangiogenic treatment impacts the nerve fibers associated with peritoneal endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To investigate the effect of antiangiogenic treatment on experimental endometriotic lesion nerve fibers. DESIGN: Heterologous mouse model of endometriosis. SETTING: University Institute IVI, University Hospital La Fe. ANIMAL(S): Ovariectomized nude mice (n = 16) receiving human endometrial fragments from oocyte donors (n = 4). INTERVENTION(S): Endometrium fragments stuck in the peritoneum of 5-week-old female nude mice treated with vehicle (n = 8) and antiangiogenic agent cabergoline (n = 8; Cb(2,) 0.05 mg/kg/day) for 14 days. MAIN OUTCOME MEASURE(S): Immunofluorescence analysis of von-Willebrand factor (vWF) and vascular smooth muscle cells (αSMA) for evaluating the number of immature blood vessels (IBV) and microvascular density (MVD); immunochemical analysis of protein-gene product 9.5 (PGP 9.5) to assess nerve fibers density (NFD), and blue toluidine staining to confirm presence of mast cells and macrophages in endometriotic lesions. RESULT(S): All the results were quantified by morphometric techniques. The IBV, NFD, and number of macrophages and mast cells were statistically significantly decreased in the Cb2-treated group when compared with controls. CONCLUSION(S): Antiangiogenic treatment statistically significantly diminishes new blood vessel formation after macrophage, mast cell, and nerve fiber reduction, providing a rationale to test antiangiogenic agents as a novel therapeutic approach to severe pelvic pain associated with human peritoneal endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Angiogenesis Inhibitors Endometriosis Endometrium Ergolines Microvessels Neovascularization, Pathologic Neovascularization, Pathologic Nerve Fibers Peritoneal Diseases Actins Actins Actins Angiogenesis Inhibitors Angiogenesis Inhibitors Animals Animals Biomarkers Biomarkers Biomarkers Cabergoline

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (66)

Cited by (40)

Source provenance

europepmc
last seen: 2026-10-15T06:08:49.021275+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:10:46.340120+00:00
License: CC0 · commercial use OK